3.56
price up icon8.87%   0.29
pre-market  Vorhandelsmarkt:  2.74   -0.82   -23.03%
loading

Neuronetics Inc Aktie (STIM) Neueste Nachrichten

pulisher
12:48 PM

Neuronetics announces public stock offering By Investing.com - Investing.com Nigeria

12:48 PM
pulisher
Feb 06, 2025

Neuronetics announces public stock offering - Investing.com India

Feb 06, 2025
pulisher
Feb 06, 2025

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - The Manila Times

Feb 06, 2025
pulisher
Feb 06, 2025

Major Stock Offering Alert: Neuronetics Takes Bold Step to Raise Capital Through Public Markets - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Neuronetics Inc (STIM) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Medical Transcranial Magnetic Stimulator Market Generated - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Neuronetics Inc (STIM)’s stock chart: A technical perspective - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Market Momentum Report: Neuronetics Inc (STIM)’s Positive Close at 3.45 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Neuronetics Inc (STIM) rating downgrades by William Blair - Knox Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Unlocking the Healthcare Boom: Why Neuronetics is a Game-Changer for Investors - Jomfruland.net

Feb 03, 2025
pulisher
Feb 03, 2025

Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025
pulisher
Feb 02, 2025

Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Drops By 35.8% - MarketBeat

Feb 02, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression - The Manila Times

Jan 29, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:32 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:31 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Neuronetics, Inc. Unveils Two Significant Publications on TMS Therapy for Depression - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Neuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five years - Yahoo Finance

Jan 29, 2025
pulisher
Jan 29, 2025

Breakthrough Depression Treatment Achieves Universal Success Rate, Research Confirms - StockTitan

Jan 29, 2025
pulisher
Jan 24, 2025

Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance - MSN

Jan 24, 2025
pulisher
Jan 20, 2025

Neuronetics (NASDAQ: STIM) Files 8-K with Preliminary Financial Information - Defense World

Jan 20, 2025
pulisher
Jan 14, 2025

Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024 - Marketscreener.com

Jan 14, 2025
pulisher
Jan 14, 2025

Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Drop in Short Interest - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Neuronetics forecasts revenue growth and cost savings post-acquisition - Investing.com India

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Projects Growth Following Greenbrook Acquisition - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Provides Business Update and Issues 2025 Guidance - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Projects Strong 2025 Growth, Expands NeuroStar Depression Treatment to Teens - StockTitan

Jan 13, 2025
pulisher
Jan 11, 2025

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 43% Yet They're Still Not Telling The Full Story - Simply Wall St

Jan 11, 2025
pulisher
Jan 08, 2025

Transcranial Magnetic Stimulator Market Growth in Future Scope - openPR

Jan 08, 2025
pulisher
Jan 07, 2025

Transcranial Magnetic Stimulator Market Report, Size, Trends, - openPR

Jan 07, 2025
pulisher
Jan 07, 2025

Critical Survey: Neuronetics (NASDAQ:STIM) vs. Tenon Medical (NASDAQ:TNON) - Defense World

Jan 07, 2025
pulisher
Jan 03, 2025

Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN

Jan 03, 2025
pulisher
Jan 02, 2025

Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St

Jan 02, 2025
pulisher
Dec 26, 2024

HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Dec 26, 2024
pulisher
Dec 23, 2024

Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com

Dec 23, 2024
pulisher
Dec 20, 2024

Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN

Dec 20, 2024
pulisher
Dec 19, 2024

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 19, 2024
pulisher
Dec 18, 2024

Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan

Dec 18, 2024
pulisher
Dec 17, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 16, 2024

Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com

Dec 16, 2024
pulisher
Dec 11, 2024

Neuronetics, Greenbrook TMS close transaction - Medical Buyer

Dec 11, 2024
pulisher
Dec 10, 2024

Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times

Dec 10, 2024
pulisher
Dec 10, 2024

Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times

Dec 10, 2024
pulisher
Dec 07, 2024

Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World

Dec 07, 2024
pulisher
Dec 05, 2024

Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria

Dec 05, 2024
$122.80
price down icon 1.51%
diagnostics_research LH
$247.74
price down icon 0.90%
$175.14
price down icon 1.05%
diagnostics_research WAT
$410.95
price down icon 0.76%
diagnostics_research MTD
$1,357.26
price down icon 0.46%
$460.56
price down icon 1.71%
Kapitalisierung:     |  Volumen (24h):